newsfilter
← Latest News
GlobeNewswire·

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Phase 2b NAVIGATE clinical trial evaluating CD388 for the prevention of seasonal influenza met primary and all secondary efficacy endpoints for all dose groupsEnd of Phase 2 meeting request submitted to the U.S. Food and